| Name | Title | Contact Details |
|---|
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a “switched off” or inactivated conformation. Deciphera has developed a diverse pipeline of drug candidates designed to improve outcomes for patients with cancer by enhancing the quality, rate and/or durability of their responses to treatment.
PCI is a leading provider of integrated pharmaceutical development services to the global healthcare market.
Validation Resources is a Bend, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The UroLift System is an FDA Cleared, revolutionary minimally invasive treatment of Benign Prostatic Hyperplasia (BPH) or an enlarged prostate.
Red Nucleus is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.